อ้างอิง ของ ไลโพโปรตีนหนาแน่นต่ำ

  1. ↑ "LDL and HDL: Bad and Good Cholesterol". Centers for Disease Control and Prevention. CDC. สืบค้นเมื่อ 2017-09-11.
  2. ↑ Dashti, M; Kulik, W; Hoek, F; Veerman, EC; Peppelenbosch, MP; Rezaee, F (2011). "A phospholipidomic analysis of all defined human plasma lipoproteins". Sci. Rep. 1 (139). doi:10.1038/srep00139. PMC 3216620. PMID 22355656.CS1 maint: Uses authors parameter (link)
  3. ↑ Dashty, M; Motazacker, MM; Levels, J; de Vries, M; Mahmoudi, M; Peppelenbosch, MP; Rezaee, F (2014). "Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism". Thromb. Haemost. 111: 518–530. doi:10.1160/TH13-02-0178. PMID 24500811.CS1 maint: Uses authors parameter (link)
  4. 1 2 Segrest, JP; Jones, MK; De Loof, H; Dashti, N (September 2001). "Structure of apolipoprotein B-100 in low density lipoproteins". Journal of Lipid Research. 42 (9): 1346–67. PMID 11518754.CS1 maint: Uses authors parameter (link)
  5. ↑ Glagov, Seymour; Weisenberg, Elliot; Zarins, Christopher K.; Stankunavicius, Regina; Kolettis, George J. (1987-05-28). "Compensatory Enlargement of Human Atherosclerotic Coronary Arteries". N. Engl. J. Med. 316 (22): 1371–1375. doi:10.1056/NEJM198705283162204. PMID 3574413 – โดยทาง Taylor and Francis+NEJM.
  6. ↑ Campos, Hannia (1992). "LDL Particle Size Distribution". Arteriosclerosis, Thrombosis, and Vascular Biology. 12: 1410–1419. doi:10.1161/01.ATV.12.12.1410.
  7. ↑ Kumar, V; Butcher, SJ; Katrina, O; Engelhardt, P; Heikkonen, J; Kaski, K; Ala-Korpela, M; Kovanen, PT (May 2011). "Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16? Resolution at Physiological Body Temperature". PLoS ONE. 6 (5): e18841. doi:10.1371/journal.pone.0018841. PMC 3090388. PMID 21573056.CS1 maint: Uses authors parameter (link)
  8. ↑ Zhang, Da-Wei; Garuti, Rita; Tang, Wan-Jin; Cohen, Jonathan C.; Hobbs, Helen H. (2008-09-02). "Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor". Proceedings of the National Academy of Sciences of the United States of America. 105 (35): 13045–13050. doi:10.1073/pnas.0806312105. ISSN 0027-8424. PMC 2526098. PMID 18753623.
  9. ↑ Davies, DG; Parsek, MR; Pearson, JP; Iglewski, BH; Costerton, JW; Greenberg, EP (1998). "The involvement of cell-to-cell signals in the development of a bacterial biofilm". Science.CS1 maint: Uses authors parameter (link)
  10. ↑ "http://cronodon.com/BioTech/Bacteria_communications.html". Cronodon. Archived from the original on 2018-04-11. สืบค้นเมื่อ 2018-12-03. External link in |title= (help)
  11. ↑ Peterson, MM; Mack, JL; Hall, PR และคณะ (December 2008). "Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection". Cell Host & Microbe. 4 (6): 555–66. doi:10.1016/j.chom.2008.10.001. PMC 2639768. PMID 19064256.CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  12. ↑ Ivanova, EA; Myasoedova, VA; Melnichenko, AA; Grechko, AV; Orekhov, AN (2017). "Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases". Oxidative Medicine and Cellular Longevity. 2017: 1273042. doi:10.1155/2017/1273042. PMC 5441126. PMID 28572872.CS1 maint: Uses authors parameter (link)
  13. ↑ Bhalodkar, Narendra C.; Blum, Steve; Rana, Thakor; Kitchappa, Radha; Bhalodkar, Ami N.; Enas, Enas A. (2005-05-01). "Comparison of high-density and low-density lipoprotein cholesterol subclasses and sizes in asian indian women with caucasian women from the framingham offspring study". Clin Cardiol. 28 (5): 247–251. doi:10.1002/clc.4960280510 – โดยทาง Wiley Online Library.
  14. ↑ Superko, HR; Nejedly, M; Garrett, B (2002). "Small LDL and its clinical importance as a new CAD risk factor: a female case study". Progress in Cardiovascular Nursing. 17 (4): 167–73. doi:10.1111/j.0889-7204.2002.01453.x. PMID 12417832.CS1 maint: Uses authors parameter (link)
  15. 1 2 Warnick, GR; Knopp, RH; Fitzpatrick, V; Branson, L (January 1990). "Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints". Clinical Chemistry. 36 (1): 15–9. PMID 2297909.CS1 maint: Uses authors parameter (link)
  16. ↑ Otvos, J (June 1999). "Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy". Clin Cardiol. 22 (6 Suppl): II21–7. doi:10.1002/clc.4960221405. PMID 10376193.
  17. ↑ Brunzell, John D; Davidson, Michael; Furberg, Curt D; Goldberg, Ronald B; Howard, Barbara V; Stein, James H; Witztum, Joseph L (2008). "Lipoprotein Management in Patients With Cardiometabolic Risk". J Am Coll Cardiol. 51: 1512–1524. Archived from the original on 2012-02-27.CS1 maint: Uses authors parameter (link)
  18. ↑ Friedewald, WT; Levy, RI; Fredrickson, DS (June 1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge". Clinical Chemistry. 18 (6): 499–502. PMID 4337382.CS1 maint: Uses authors parameter (link)
  19. ↑ Sniderman, AD; Blank, D; Zakarian, R; Bergeron, J; Frohlich, J (October 2003). "Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula". Clinical Biochemistry. 36 (7): 499–504. doi:10.1016/S0009-9120(03)00117-6. PMID 14563441.CS1 maint: Uses authors parameter (link)
  20. ↑ http://www.liposcience.com/userfiles/content/files/weightofevidence.pdf[ลิงก์เสีย]
  21. ↑ "Cholesterol Levels". American Heart Association. สืบค้นเมื่อ 2009-11-14.
  22. ↑ "What Do My Cholesterol Levels Mean?" (PDF). American Heart Association. September 2007. สืบค้นเมื่อ 2009-11-14.
  23. ↑ "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary" (PDF). National Heart, Lung, and Blood Institute (NHLBI). National Institutes of Health. May 2001.
  24. ↑ Shepherd, J; Cobbe, SM; Ford, I และคณะ (November 1995). "Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group". The New England Journal of Medicine. 333 (20): 1301–7. doi:10.1056/NEJM199511163332001. PMID 7566020.CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  25. ↑ William E. Boden, M.D.; และคณะ (April 2007). "Optimal Medical Therapy with or without PCI for Stable Coronary Disease". The New England Journal of Medicine. 356 (15): 1503–1516. doi:10.1056/NEJMoa070829. PMID 17387127.
  26. ↑ Hayward, Rodney A. (2006-10-03). "Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem". Ann Intern Med. 145 (7): 520–30. doi:10.7326/0003-4819-145-7-200610030-00010. PMID 17015870.
  27. ↑ "The straight dope on cholesterol - Part VI - The Eating Academy - Peter Attia, M.D." 2012-05-30.
  28. ↑ "Google".
  29. ↑ Wang, Y Richard; G Caleb Alexander; David O Meltzer (December 2005). "Lack of Effect of Guideline Changes on LDL Cholesterol Reporting and Control for Diabetes Visits in the U.S., 1995-2004". Diabetes Care. 28 (12): 2942–2944. doi:10.2337/diacare.28.12.2942. PMID 16306559. สืบค้นเมื่อ 2011-11-11.
  30. ↑ Toth, Peter P; Grabner, Michael; Punekar, Rajeshwari S; Quimbo, Ralph A; Cziraky, Mark J; Jacobson, Terry A (August 2014). "Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets". Atherosclerosis. 235 (2): 585–591. doi:10.1016/j.atherosclerosis.2014.05.914.CS1 maint: Uses authors parameter (link)
  31. ↑ Krauss, RM (August 2010). "Lipoprotein subfractions and cardiovascular disease risk". Current Opinion in Lipidology. 21 (4): 305–11. doi:10.1097/MOL.0b013e32833b7756. PMID 20531184.
  32. ↑ Brunzell, John D.; Davidson, Michael; Furberg, Curt D.; Goldberg, Ronald B.; Howard, Barbara V.; Stein, James H.; Witztum, Joseph L. (2008-04-15). "Lipoprotein Management in Patients With Cardiometabolic Risk". J Am Coll Cardiol. 51 (15): 1512–1524. doi:10.1016/j.jacc.2008.02.034. Archived from the original on 2012-02-27. สืบค้นเมื่อ 2010-05-09.
  33. ↑ "Google".
  34. ↑ "Archived copy". Archived from the original on 2014-11-25. สืบค้นเมื่อ 2014-11-16.CS1 maint: Archived copy as title (link)
  35. ↑ Morris, Pamela. "ATP IV, CVD Risk Assessment, and Dyslipidemia: Update 2012" (PDF). Archived from the original (PDF) on 2016-03-03. สืบค้นเมื่อ 2014-11-16.CS1 maint: Uses authors parameter (link)
  36. 1 2 3 4 5 6 7 8 Consumer Reports; Drug Effectiveness Review Project (March 2013), "Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price" (PDF), Best Buy Drugs, Consumer Reports, p. 9, สืบค้นเมื่อ 2013-03-27 อ้างอิง
  37. ↑ Research, Center for Drug Evaluation and. "Drug Safety Information for Heathcare [sic] Professionals - Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor)".
  38. ↑ Meyers, CD; Kamanna, VS; Kashyap, ML (December 2004). "Niacin therapy in atherosclerosis". Current Opinion in Lipidology. 15 (6): 659–65. doi:10.1097/00041433-200412000-00006. PMID 15529025.CS1 maint: Uses authors parameter (link)
  39. 1 2 Soudijn, W; van Wijngaarden, I; Ijzerman, AP (May 2007). "Nicotinic acid receptor subtypes and their ligands". Medicinal Research Reviews. 27 (3): 417–33. doi:10.1002/med.20102. PMID 17238156.CS1 maint: Uses authors parameter (link)
  40. ↑ "WHO cooperative trial on primary prevention of ischemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators". Lancet. 2 (8403): 600–4. September 1984. doi:10.1016/s0140-6736(84)90595-6. PMID 6147641.
  41. ↑ "TRILIPIX (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 2008" (PDF). AbbVie Inc. June 2016. Archived from the original (PDF) on 2016-06-29.
  42. ↑ Song, B.L.; DeBose-Boyd, R.A. (2006). "Insig-Dependent Ubiquitination and Degradation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Stimulated by Delta- and Gamma-Tocotrienols". J. Biol. Chem. 281 (35): 25054–25601. doi:10.1074/jbc.M605575200. PMID 16831864.
  43. ↑ European Food Safety Authority, Journal (2010). "Scientific opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations".
  44. ↑ Genser, B.; Silbernagel, G.; De Backer, G.; Bruckert, E.; Carmena, R.; Chapman, M.J.; Deanfield, J.; Descamps, O.S.; Rietzschel, E.R.; Dias, K.C.; M?rz, W. (2012). "Plant sterols and cardiovascular disease: A systematic review and meta-analysis". European Heart Journal. 33 (4): 444–451. doi:10.1093/eurheartj/ehr441. PMC 3279314. PMID 22334625.
  45. ↑ Demonty, I.; Ras, R.T.; van der Knaap, H.C.; Duchateau, G.S.; Meijer, L.; Zock, P.L.; Geleijnse, J.M.; Trautwein, E.A. (February 2009). "Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake". The Journal of Nutrition. 139 (2): 271–84. doi:10.3945/jn.108.095125. PMID 19091798.
  46. ↑ "The Medical Biochemistry Page". Archived from the original on 2018-12-15.
  47. ↑ Teissedre, P.L; Frankel, E.N.; Waterhouse, A.L.; Peleg, H.; German, J.B. (1996). "Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines". J-sci-food-agric. 70 (1): 55–61. Archived from the original on 2007-10-17.CS1 maint: Uses authors parameter (link)
  48. ↑ Esterbauer, H; Puhl, H; Dieber-Rotheneder, M; Waeg, G; Rabl, H (1991). "Effect of antioxidants on oxidative modification of LDL". Annals of Medicine. 23 (5): 573–81. doi:10.3109/07853899109150520. PMID 1756027.CS1 maint: Uses authors parameter (link)
  49. ↑ Stocker, R; Jr)), ((Keaney JF (2004). "Role of oxidative modifications in atherosclerosis". Physiol Rev. 84 (4): 1381–478. doi:10.1152/physrev.00047.2003. PMID 15383655.CS1 maint: Uses authors parameter (link)

แหล่งที่มา

WikiPedia: ไลโพโปรตีนหนาแน่นต่ำ http://cronodon.com/BioTech/Bacteria_communication... http://eatingacademy.com/nutrition/the-straight-do... http://www.liposcience.com/userfiles/content/files... http://www.rxabbott.com/pdf/trilipix_pi.pdf http://onlinelibrary.wiley.com/doi/10.1002/clc.496... http://www.efsa.europa.eu/en/efsajournal/pub/1813 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrug... http://www.nhlbi.nih.gov/guidelines/cholesterol/at... http://www.nhlbi.nih.gov/health-pro/guidelines/cur... http://www.nhlbi.nih.gov/health/public/heart/chol/...